Delivery Order SPE2DB22D1103-SPE2DB24FTEE9
- Not listed
- The federal contract award is for the delivery of Dupixent 300 mg/2 ml pens, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $2,632.07, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 11, 2022. The contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award was made to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $12,710.16 and an ultimate completion date of July 20, 2023. It is a delivery order contract with a firm fixed-price pricing type. The contract does not have a...
- The federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA). The contract has a ceiling value of $12,034.58 and was awarded to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical, a subcomponent of the U.S. Department of Defense. The contract, valued at $32,068.08, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $4,088.88, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen 2 ml pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $12,109.75 and is a firm fixed-price delivery order with a completion date of November 8, 2023. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Dupixent 300 mg/2 ml pens. The contract, valued at $4,033.36, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract is a firm fixed-price delivery order with an ultimate completion date of October 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $17,738.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Dupixent 300 mg/2 ml pens, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The total ceiling value of the delivery order is $35,438.88, with a completion date of January 19, 2024. The contract is issued under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,115.23 and an ultimate completion date of November 4, 2022. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTEE9Delivery Order
The federal contract award is for the delivery of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, to support military and federal healthcare programs. The award, valued at $18,948.48, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a delivery order contract with a firm fixed price pricing type, and an ultimate completion date of January 24, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare needs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 1/23/24 |